Patritumab (P) or placebo (PBO) plus cetuximab (C) and platinum-based therapy in squamous cell carcinoma of the head and neck (SCCHN): a phase 2 study.

Authors

null

Kevin J. Harrington

Royal Marsden Hospital/Institute of Cancer Research, London, United Kingdom

Kevin J. Harrington , Martin David Forster , Magnus Dillon , Lorna Grove , Sola Adeleke , Shuquan Chen , Jane S. Diamond , Henrik Hannus , Kandance Cooper , Jonathan Greenberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT02633800

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS6104)

DOI

10.1200/JCO.2016.34.15_suppl.TPS6104

Abstract #

TPS6104

Poster Bd #

424b

Abstract Disclosures